SCHEMBL17658482

SCHEMBL17658482

c1ccc(-c2ccc(N(c3ccccc3)c3ccc(-c4ccc5c(c4)oc4c6ccc(-c7ccc(N(c8ccccc8)c8ccc(-c9ccccc9)cc8)cc7)cc6c6ccccc6c54)cc3)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.35
PLA2G4A P47712 4/20 0.35
CCNC P24863 1/20 0.34
CDK8 P49336 1/20 0.34
PRKDC P78527 1/20 0.33
KDM4E B2RXH2 3/20 0.32
MAPT P10636 3/20 0.32
MEN1 O00255 3/20 0.32
HPGD P15428 3/20 0.32
KMT2A Q03164 3/20 0.32
GAA P10253 2/20 0.32
RECQL P46063 2/20 0.32
BLM P54132 2/20 0.32
CYP3A4 P08684 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
CASP7 P55210 2/20 0.32
HSD17B10 Q99714 2/20 0.32
ALPI P09923 1/20 0.32
PKM P14618 1/20 0.32
CASP3 P42574 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17658713 0.99 PLA2G2A (0.35) PLA2G2APLA2G4ACCNCCDK8PRKDC
SCHEMBL17658480 0.99 KDM4E (0.33) PLA2G2APLA2G4ACCNCCDK8PRKDC
SCHEMBL20845453 0.97 CCNC (0.35) PLA2G2APLA2G4ACCNCCDK8PRKDC
SCHEMBL17658510 0.96 PLA2G2A (0.34) PLA2G2APLA2G4ACCNCCDK8PRKDC
SCHEMBL17658490 0.96 PLA2G2A (0.34) PLA2G2APLA2G4ACCNCCDK8PRKDC
SCHEMBL24527214 0.96 KDM4E (0.34) PLA2G2APLA2G4ACCNCCDK8PRKDC
SCHEMBL17658415 0.95 MEN1 (0.32) PLA2G2APLA2G4AKDM4EMAPTMEN1
SCHEMBL17658495 0.95 CCNC (0.34) PLA2G2APLA2G4ACCNCCDK8PRKDC
SCHEMBL19152326 0.94 CCNC (0.33) PLA2G2APLA2G4ACCNCCDK8PRKDC
SCHEMBL17658470 0.92 DYRK1A (0.33) KDM4EMAPTMEN1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9923147-B2 Organic light emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-20 US disclosed
US-9923147-B2 Organic light emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-20 US disclosed
US-9856243-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-02 US disclosed
US-20160329501-A1 ORGANIC LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2016-11-10 US disclosed
US-20160329501-A1 ORGANIC LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2016-11-10 US disclosed
US-20160099423-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-04-07 US disclosed
US-20160099423-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160099423-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, MCM4 PLA2G2A 4629/4885PLA2G4A 4587/4885CCNC 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.